ICEID Coverage

Global health security is a growing field that continues to evolve. The COVID-19 pandemic has especially emphasised the greatest needs and opportunities for progress in low- and middle-income countries, where systems are not yet in place to address emerging infectious disease threats, as well as in high-income countries, which also present large systems-related gaps. Developing […]

Global health security is a growing field that continues to evolve. The COVID-19 pandemic has especially emphasised the greatest needs and opportunities for progress in low- and middle-income countries, where systems are not yet in place to address emerging infectious disease threats, as well as in high-income countries, which also present large systems-related gaps. Developing […]

Multidrug-resistant tuberculosis (MDR-TB) refers to the case when a clinical TB isolate is resistant to two of the most potent tuberculosis medications: isoniazid and rifampin. Globally, there are about half a million new cases of MDR-TB per year. Prof. Timothy Rodwell (UC San Diego, San Diego, CA, US) talked to us about the advantages, efficacy and cost-effectiveness […]

Multidrug-resistant tuberculosis (MDR-TB) refers to the case when a clinical TB isolate is resistant to two of the most potent tuberculosis medications: isoniazid and rifampin. Globally, there are about half a million new cases of MDR-TB per year. Prof. Timothy Rodwell (UC San Diego, San Diego, CA, US) discusses the limitations of MDR-TB diagnosis and assessment as […]

The recent outbreak of COVID-19 has provided new insight into the importance of communicating science to the public and policymakers, health equity issues, and the global aspects of a pandemic. In this interview, Dr John Sharfstein (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA) discusses the importance of effective science communication and its […]

An estimated 354 million people worldwide live with hepatitis B or C, and for most, testing and treatment remain beyond reach. Consequently, the World Health Organization (WHO) has set the goal of eliminating hepatitis B and C by 2030. Dr Nicole Seguy (Regional Advisor HIV, hepatitis and STIs, WHO/Europe) summarizes the existing landscape of hepatitis […]